Immunomodulation
US4803072A · kind A · utility
25Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 10, 1986 |
| Grant date | Feb 7, 1989 |
| Priority date | — |
| Expiry date | Sep 10, 2006 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An immunomodulating pharmaceutical composition comprising an effective, leukocyte interferon production inducing amount of NS1 and a pharmaceutically acceptable carrier or diluent; and a method of modulating the immune response in a human or other animal in need thereof by inducing the production of leukocyte IFN which comprises administering an effective amount of NS1 to such human or animal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.